期刊文献+

Shexiang Tongxin dropping pill(麝香通心滴丸)protects against sodium laurate-induced coronary microcirculatory dysfunction in rats 被引量:7

原文传递
导出
摘要 OBJECTIVE:To investigate the protective effects of Shexiang Tongxin dropping pill(麝香通心滴丸,STDP)in a rat model of coronary microcirculatory dysfunction(CMD).METHODS:Sprague-Dawley rats were allocated randomly into four groups:sham,CMD model,STDP,and nicorandil.After 4 weeks of treatment,CMD was induced by injection of sodium laurate(0.2 m L,2 g/L)into the left ventricle while obstructing the ascending aorta.Rats in the sham group underwent an identical surgical procedure but were administered physiological(0.9%)saline(0.2 m L).Twenty-four hours after surgery,blood samples were collected for biochemical analyses and enzyme-linked immunosorbent assays.Heart tissues were removed for histopathology staining;apoptosis and inflammatory cytokines were examined by Western blotting.RESULTS:The STDP group had a lower level of creatine kinase-myocardial band,lactate dehydrogenase,and cardiac troponin-I than that in the CMD model group.Infiltration of inflammatory cells,myocardial ischaemia,and microthrombosis were relieved in the STDP group compared with CMD model group.Levels of endothelin-1,nuclear factor-kappa B,tumour necrosis factor-α,interleukin-6,interleukin-1β,malondialdehyde,B-cell lymphoma(Bcl)-2-associated X protein,and caspase-3 were lower,and levels of nitric oxide,Bcl-2,and superoxide dismutase were higher,in the STDP group in comparison with the CMD model group.CONCLUSION:STDP pretreatment improved the CMD induced by sodium laurate via anti-inflammatory,anti-apoptosis,and anti-oxidant mechanisms.
出处 《Journal of Traditional Chinese Medicine》 SCIE CSCD 2021年第1期89-97,共9页 中医杂志(英文版)
基金 Supported by Zhejiang Medicine and Technology Plan(No.2018KY827) Zhejiang TCM Science and Technology Plan(No.2018ZB130)-funded Project the Study of the Protective Effects of Shexiang Tongxin dropping pill on Coronary Microcirculatory Dysfunction。
  • 相关文献

参考文献2

二级参考文献54

  • 1尚晓滨,吴咸中,薛小平,杨秀竹,李东华,郭世铎.活血化瘀中药对清解通下中药增效作用的实验研究IV——大鼠腹膜粘连组织羟脯氨酸和I、III型胶原含量测定[J].中国中西医结合外科杂志,2006,12(3):254-257. 被引量:7
  • 2沈成兴,梁春,陈良龙,钱菊英,王克强,陈灏珠,葛均波.经冠状动脉内注射月桂酸钠构建大鼠冠状动脉微栓塞模型[J].中国动脉硬化杂志,2005,13(4):447-450. 被引量:25
  • 3尚晓滨,吴咸中,李东华,郭世铎.活血化瘀中药对清解通下中药增效作用的实验研究I——治疗急性细菌性腹膜炎的实验观察[J].中国中西医结合外科杂志,2006,12(2):91-94. 被引量:13
  • 4Morice MC,Serruys PW,Sousa JE,Fajadet J,Ban Hayashi E,Perin M,Colombo A,Schuler G,Barragan P,Guagliumi G,Molnàr F,Falotico R;RAVEL Study Group.A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.N Engl J Med.2002;346(23):1773-1780.
  • 5Moses JW,Leon MB,Popma JJ,Fitzgerald PJ,Holmes DR,O'Shaughnessy C,Caputo RP,Kereiakes DJ,Williams DO,Teirstein PS,Jaeger JL,Kuntz RE;SIRIUS Investigators.Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.N Engl J Med.2003;349(14):1315-1323.
  • 6Virmani R,Guagliumi G,Farb A,Musumeci G,Grieco N,Motta T,Mihalcsik L,Tespili M,Valsecchi O,Kolodgie FD.Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stem:should we be cautious?Circulation.2004;109(6):701-705.
  • 7Camenzind E,Steg PG,Wijns W.Stent thrombosis late after implantation of first-generation drug-eluting stents:a cause for concern.Circulation.2007:115(11):1440-1455.
  • 8Daemen J,Wenaweser P,Tsuchida K,Abrecht L,Vaina S,Morger C,Kukreja N.Jüni P,Sianos G,Hellige G,van Domburg RT.Hess OM,Boersma E,Meier B,Windecker S,Serruys PW.Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxeI-eluting stents in routine clinical practice:data from a large two-institutional cohort study.Lancet.2007;369(9562):667-678.
  • 9Wenaweser P,Daemen J,Zwahlen M,van Domburg R,Jüni P,Vaina S,Hellige G,Tsuchida K,Morger C,Boersma E,Kukreja N,Meier B,Serruys PW,Windecker S.Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice:4-year results from a large 2-institutional cohort study.J Am Coll Cardiol.2008:52(14):1134-1140.
  • 10Yusuf S,Zhao F,Mehta SR,Chrolavicius S,Tognoni G,Fox KK.Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.N Engl J Med.2001;345(7):494-502.

共引文献30

同被引文献90

引证文献7

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部